Agrifoglio, O.; Kasprick, A.; Gross, N.; Wahlig, M.; Kauffold, E.; Woitas, A.; Vorobyev, A.; Ehlers, L.; Ludwig, R.J.; Bieber, K.;
et al. Dexamethasone’s Clinical Efficacy in Experimental Autoimmune Pancreatitis Correlates with a Unique Transcriptomic Signature, Whilst Kinase Inhibitors Are Not Effective. Biomedicines 2024, 12, 2480.
https://doi.org/10.3390/biomedicines12112480
AMA Style
Agrifoglio O, Kasprick A, Gross N, Wahlig M, Kauffold E, Woitas A, Vorobyev A, Ehlers L, Ludwig RJ, Bieber K,
et al. Dexamethasone’s Clinical Efficacy in Experimental Autoimmune Pancreatitis Correlates with a Unique Transcriptomic Signature, Whilst Kinase Inhibitors Are Not Effective. Biomedicines. 2024; 12(11):2480.
https://doi.org/10.3390/biomedicines12112480
Chicago/Turabian Style
Agrifoglio, Ottavia, Anika Kasprick, Natalie Gross, Marc Wahlig, Emilia Kauffold, Aline Woitas, Artem Vorobyev, Luise Ehlers, Ralf J. Ludwig, Katja Bieber,
and et al. 2024. "Dexamethasone’s Clinical Efficacy in Experimental Autoimmune Pancreatitis Correlates with a Unique Transcriptomic Signature, Whilst Kinase Inhibitors Are Not Effective" Biomedicines 12, no. 11: 2480.
https://doi.org/10.3390/biomedicines12112480
APA Style
Agrifoglio, O., Kasprick, A., Gross, N., Wahlig, M., Kauffold, E., Woitas, A., Vorobyev, A., Ehlers, L., Ludwig, R. J., Bieber, K., & Jaster, R.
(2024). Dexamethasone’s Clinical Efficacy in Experimental Autoimmune Pancreatitis Correlates with a Unique Transcriptomic Signature, Whilst Kinase Inhibitors Are Not Effective. Biomedicines, 12(11), 2480.
https://doi.org/10.3390/biomedicines12112480
